• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

构象缺陷是 ClC-5 致 Dent 病突变体被蛋白酶体降解的基础。

Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5.

机构信息

Programme in Molecular Structure and Function, Research Institute, Hospital for Sick Children, Toronto, Canada M5G 1X8.

出版信息

Biochem J. 2013 Jun 15;452(3):391-400. doi: 10.1042/BJ20121848.

DOI:10.1042/BJ20121848
PMID:23566014
Abstract

Mutations in the CLCN5 (chloride channel, voltage-sensitive 5) gene cause Dent's disease because they reduce the functional expression of the ClC-5 chloride/proton transporter in the recycling endosomes of proximal tubule epithelial cells. The majority (60%) of these disease-causing mutations in ClC-5 are misprocessed and retained in the ER (endoplasmic reticulum). Importantly, the structural basis for misprocessing and the cellular destiny of such ClC-5 mutants have yet to be defined. A ClC-5 monomer comprises a short N-terminal region, an extensive membrane domain and a large C-terminal domain. The recent crystal structure of a eukaryotic ClC (chloride channel) transporter revealed the intimate interaction between the membrane domain and the C-terminal region. Therefore we hypothesized that intramolecular interactions may be perturbed in certain mutants. In the present study we examined two misprocessed mutants: C221R located in the membrane domain and R718X, which truncates the C-terminal domain. Both mutants exhibited enhanced protease susceptibility relative to the normal protein in limited proteolysis studies, providing direct evidence that they are misfolded. Interestingly, the membrane-localized mutation C221R led to enhanced protease susceptibility of the cytosolic N-terminal region, and the C-terminal truncation mutation R718X led to enhanced protease susceptibility of both the cytosolic C-terminal and the membrane domain. Together, these studies support the idea that certain misprocessing mutations alter intramolecular interactions within the full-length ClC-5 protein. Further, we found that these misfolded mutants are polyubiquitinated and targeted for proteasomal degradation in the OK (opossum kidney) renal epithelial cells, thereby ensuring that they do not elicit the unfolded protein response.

摘要

CLCN5(氯离子通道,电压敏感 5)基因突变导致 Dent 病,因为它们降低了近端肾小管上皮细胞再循环内体中 ClC-5 氯离子/质子转运体的功能表达。这些 CLCN5 中的大多数(60%)致病突变是错误加工并保留在内质网(内质网)中。重要的是,错误加工的结构基础和此类 ClC-5 突变体的细胞命运尚未确定。ClC-5 单体包括短的 N 端区域、广泛的膜结构域和大的 C 端结构域。最近真核 ClC(氯离子通道)转运蛋白的晶体结构揭示了膜结构域和 C 端区域之间的密切相互作用。因此,我们假设某些突变体中可能会破坏分子内相互作用。在本研究中,我们检查了两种错误加工的突变体:位于膜结构域中的 C221R 和截断 C 端结构域的 R718X。在有限的蛋白水解研究中,这两种突变体相对于正常蛋白表现出增强的蛋白酶敏感性,这直接证明它们是错误折叠的。有趣的是,膜定位突变 C221R 导致细胞质 N 端区域的蛋白酶敏感性增强,而 C 端截断突变 R718X 导致细胞质 C 端和膜结构域的蛋白酶敏感性增强。总之,这些研究支持这样的观点,即某些错误加工的突变改变全长 ClC-5 蛋白内的分子内相互作用。此外,我们发现这些错误折叠的突变体被多聚泛素化,并在 OK(袋熊肾)肾上皮细胞中被靶向蛋白酶体降解,从而确保它们不会引发未折叠蛋白反应。

相似文献

1
Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of ClC-5.构象缺陷是 ClC-5 致 Dent 病突变体被蛋白酶体降解的基础。
Biochem J. 2013 Jun 15;452(3):391-400. doi: 10.1042/BJ20121848.
2
ClC-5 mutations associated with Dent's disease: a major role of the dimer interface.与 Dent 病相关的 ClC-5 突变:二聚体界面的主要作用。
Pflugers Arch. 2012 Feb;463(2):247-56. doi: 10.1007/s00424-011-1052-0. Epub 2011 Nov 15.
3
Novel CLCN5 mutations in patients with Dent's disease result in altered ion currents or impaired exchanger processing.丹特病患者中新型CLCN5突变导致离子电流改变或交换体加工受损。
Kidney Int. 2009 Nov;76(9):999-1005. doi: 10.1038/ki.2009.305. Epub 2009 Aug 5.
4
Heterogeneity in the processing of CLCN5 mutants related to Dent disease.Dent 病相关 CLCN5 突变体的处理中的异质性。
Hum Mutat. 2011 Apr;32(4):476-83. doi: 10.1002/humu.21467.
5
A pure chloride channel mutant of CLC-5 causes Dent's disease via insufficient V-ATPase activation.CLC-5的一种纯合氯离子通道突变体通过V-ATP酶激活不足导致丹特病。
Pflugers Arch. 2016 Jul;468(7):1183-1196. doi: 10.1007/s00424-016-1808-7. Epub 2016 Apr 5.
6
Genetic Analysis of Dent's Disease and Functional Research of CLCN5 Mutations.丹特氏病的遗传分析及CLCN5突变的功能研究
DNA Cell Biol. 2017 Dec;36(12):1151-1158. doi: 10.1089/dna.2017.3731. Epub 2017 Oct 23.
7
Molecular effect of a novel missense mutation, L266V, on function of ClC-5 protein in a Japanese patient with Dent's disease.
Clin Nephrol. 2014 Jul;82(1):58-61. doi: 10.5414/CN107810.
8
Functional evaluation of Dent's disease-causing mutations: implications for ClC-5 channel trafficking and internalization.丹特病致病突变的功能评估:对氯离子通道蛋白5(ClC-5)转运和内化的影响
Hum Genet. 2005 Jul;117(2-3):228-37. doi: 10.1007/s00439-005-1303-2. Epub 2005 May 14.
9
Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure.对CLC-5的丹特氏病突变的特征分析揭示了功能和细胞生物学后果与蛋白质结构之间的相关性。
Am J Physiol Renal Physiol. 2009 Feb;296(2):F390-7. doi: 10.1152/ajprenal.90526.2008. Epub 2008 Nov 19.
10
Diversity of functional alterations of the ClC-5 exchanger in the region of the proton glutamate in patients with Dent disease 1.Dent 病 1 患者质子谷氨酸区域 ClC-5 交换器功能改变的多样性。
Hum Mutat. 2021 May;42(5):537-550. doi: 10.1002/humu.24184. Epub 2021 Mar 1.

引用本文的文献

1
Novel Dent disease 1 cellular models reveal biological processes underlying ClC-5 loss-of-function.新型 Dent 病 1 细胞模型揭示了 ClC-5 功能丧失的生物学过程。
Hum Mol Genet. 2021 Jul 9;30(15):1413-1428. doi: 10.1093/hmg/ddab131.
2
Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon.Dent 病的遗传学和表型异质性:月亮的阴暗面。
Hum Genet. 2021 Mar;140(3):401-421. doi: 10.1007/s00439-020-02219-2. Epub 2020 Aug 29.
3
The CFTR Mutation c.3453G > C (D1152H) Confers an Anion Selectivity Defect in Primary Airway Tissue that Can Be Rescued by Ivacaftor.
CFTR基因c.3453G>C(D1152H)突变导致原发性气道组织出现阴离子选择性缺陷,而依伐卡托可纠正这一缺陷。
J Pers Med. 2020 May 13;10(2):40. doi: 10.3390/jpm10020040.
4
From protein uptake to Dent disease: An overview of the CLCN5 gene.从蛋白摄取到 Dent 病:CLCN5 基因概述。
Gene. 2020 Jul 15;747:144662. doi: 10.1016/j.gene.2020.144662. Epub 2020 Apr 11.
5
Activity of lumacaftor is not conserved in zebrafish Cftr bearing the major cystic fibrosis-causing mutation.在携带主要囊性纤维化致病突变的斑马鱼Cftr中,鲁马卡托的活性并不保守。
FASEB Bioadv. 2019 Sep 18;1(10):661-670. doi: 10.1096/fba.2019-00039. eCollection 2019 Oct.
6
Genetic Analyses in Dent Disease and Characterization of CLCN5 Mutations in Kidney Biopsies.遗传性肾性尿崩症的基因分析及肾活检中 CLCN5 突变的特征。
Int J Mol Sci. 2020 Jan 14;21(2):516. doi: 10.3390/ijms21020516.
7
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators.三甲氧基补骨脂素衍生物作为囊性纤维化跨膜传导调节因子调节剂的作用分子机制
Front Pharmacol. 2018 Jul 4;9:719. doi: 10.3389/fphar.2018.00719. eCollection 2018.
8
Dent disease in Poland: what we have learned so far?波兰的丹特病:我们目前了解到了什么?
Int Urol Nephrol. 2017 Nov;49(11):2005-2017. doi: 10.1007/s11255-017-1676-x. Epub 2017 Aug 16.
9
A pure chloride channel mutant of CLC-5 causes Dent's disease via insufficient V-ATPase activation.CLC-5的一种纯合氯离子通道突变体通过V-ATP酶激活不足导致丹特病。
Pflugers Arch. 2016 Jul;468(7):1183-1196. doi: 10.1007/s00424-016-1808-7. Epub 2016 Apr 5.
10
Types and effects of protein variations.蛋白质变异的类型和影响。
Hum Genet. 2015 Apr;134(4):405-21. doi: 10.1007/s00439-015-1529-6. Epub 2015 Jan 24.